Transforming growth factor β, bone morphogenetic protein, and vascular endothelial growth factor mediate phenotype maturation and tissue remodeling by embryonic valve progenitor cells: Relevance for heart valve tissue engineering

Tissue Engineering - Part A

Volumn 16, Issue 11, 2010, Pages 3375-3383

  Chiu, Yung Nung ^a   Norris, Russell A ^b   Mahler, Gretchen ^a   Recknagel, Andrew ^a   Butcher, Jonathan T ^a  

^a Cornell University   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELL CULTURE; ENDOTHELIAL CELLS; HEART; PEPTIDES; SELF ASSEMBLY; THREE DIMENSIONAL; VALVES (MECHANICAL);

BONE MORPHOGENETIC PROTEIN-2; BONE MORPHOGENETIC PROTEINS; CELL AND TISSUE BIOLOGY; CELL MIGRATION; CELLULAR COMPOSITION; DOSE-DEPENDENT; DOSE-DEPENDENT MANNER; EMBRYONIC DEVELOPMENT; ENGINEERED TISSUES; GROWTH FACTOR; HEART VALVE DISEASE; HEART VALVES; IN-VITRO; IN-VIVO; IN-VIVO ANALYSIS; KEY IMPEDIMENTS; MATRIX; PROGENITOR CELL; SIGNALING EVENTS; TISSUE REMODELING; TISSUE RESEARCH; TRANSFORMING GROWTH FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

TISSUE ENGINEERING;

AVES;

BONE MORPHOGENETIC PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN A;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL MOTION; CHICKEN; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HEART VALVE; HUMAN; METABOLISM; ORGANOGENESIS; PHENOTYPE; PRENATAL DEVELOPMENT; STEM CELL; TISSUE ENGINEERING; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 2; CELL MOVEMENT; CHICKENS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART VALVES; HUMANS; MODELS, BIOLOGICAL; ORGANOGENESIS; PHENOTYPE; STEM CELLS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA3; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78149234492     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0027     Document Type: Article

References (38)

1. Hoffman, J.I. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol 16, 155, 1995.
2. Clark, E.B. Mechanisms in the pathogenesis of congenital cardiac malformations. In: Moller, M.E.Pa.J.H., ed. Genetics of Cardiovascular Disease. Boston, MA: Martinus-Nighoff; 1987, pp. 3-11.
3. Hammermeister, K., Sethi, G.K., Henderson, W.G., Grover, F.L., Oprian, C., and Rahimtoola, S.H. Outcomes 15 years after valve replacement with a mechanical versus a bio-prosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36, 1152, 2000.
4. Zilla, P., Brink, J., Human, P., and Bezuidenhout, D. Prosthetic heart valves: catering for the few. Biomaterials 29, 385, 2008.
5. Courtney, T., Sacks, M.S., Stankus, J., Guan, J., and Wagner, W.R. Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials 27, 3631, 2006.
6. Sodian, R., Hoerstrup, S.P., Sperling, J.S., Martin, D.P., Daebritz, S., Mayer, J.E., Jr., et al. Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves. ASAIO J 46, 107, 2000.
7. Van Lieshout, M., Peters, G., Rutten, M., and Baaijens, F. A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. Tissue Eng 12, 481, 2006.
8. Sutherland, F.W., Perry, T.E., Yu, Y., Sherwood, M.C., Rabkin, E., Masuda, Y., et al. From stem cells to viable autologous semilunar heart valve. Circulation 111, 2783, 2005.
9. Flanagan, T.C., Sachweh, J.S., Frese, J., Schnoring, H., Gron-loh, N., Koch, S., et al. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 15, 2965, 2009.
10. Taylor, P.M., Allen, S.P., and Yacoub, M.H. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J Heart Valve Dis 9, 150, 2000.
11. Butcher, J.T., and Nerem, R.M. Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. J Heart Valve Dis 13, 478; discussion 85, 2004.
12. Hoffman-Kim, D., Maish, M.S., Krueger, P.M., Lukoff, H., Bert, A., Hong, T., et al. Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves. Tissue Eng 11, 288, 2005.
13. Schnell, A.M., Hoerstrup, S.P., Zund, G., Kolb, S., Sodian, R., Visjager, J.F., et al. Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts. Thorac Cardiovasc Surg 49, 221, 2001.
14. Schaefermeier, P.K., Cabeza, N., Besser, J.C., Lohse, P., Daebritz, S.H., Schmitz, C., et al. Potential cell sources for tissue engineering of heart valves in comparison with human pulmonary valve cells. ASAIO J 55, 86, 2009.
15. Rabkin-Aikawa, E., Farber, M., Aikawa, M., and Schoen, F.J. Dynamic and reversible changes of interstitial cell pheno-type during remodeling of cardiac valves. J Heart Valve Dis 13, 841, 2004.
16. Chen, J.H., Yip, C.Y., Sone, E.D., and Simmons, C.A. Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. Am J Pathol 174, 1109, 2009.
17. Liu, A.C., Joag, V.R., and Gotlieb, A.I. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 171, 1407, 2007.
18. Aikawa, E., Whittaker, P., Farber, M., Mendelson, K., Pa-dera, R.F., Aikawa, M., et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 113, 1344, 2006.
19. Hinton, R.B., Jr., Lincoln, J., Deutsch, G.H., Osinska, H., Manning, P.B., Benson, D.W., et al. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 98, 1431, 2006.
20. Butcher, J.T., and Markwald, R.R. Valvulogenesis: the moving target. Philos Trans R Soc Lond B Biol Sci 362, 1489, 2007.
21. Armstrong, E.J., and Bischoff, J. Heart valve development: endothelial cell signaling and differentiation. Circ Res 95, 459, 2004.
22. Combs, M.D., and Yutzey, K.E. Heart valve development: regulatory networks in development and disease. Circ Res 105, 408, 2009.
23. Norris, R.A., Kern, C.B., Wessels, A., Wirrig, E.E., Mark-wald, R.R., and Mjaatvedt, C.H. Detection of betaig-H3, a TGFbeta induced gene, during cardiac development and its complementary pattern with periostin. Anat Embryol (Berl) 210, 13, 2005.
24. Okagawa, H., Markwald, R.R., and Sugi, Y. Functional BMP receptor in endocardial cells is required in atrioventricular cushion mesenchymal cell formation in chick. Dev Biol 306, 179, 2007.
25. Martinsen, B.J. Reference guide to the stages of chick heart embryology. Dev Dyn 233, 1217, 2005.
26. Butcher, J.T., Norris, R.A., Hoffman, S., Mjaatvedt, C.H., and Markwald, R.R. Periostin promotes atrioventricular mesen-chyme matrix invasion and remodeling mediated by in-tegrin signaling through Rho/PI 3-kinase. Dev Biol 302, 256, 2007.
27. Butcher, J.T., and Nerem, R.M. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng 12, 905, 2006.
28. Garg, V., Muth, A.N., Ransom, J.F., Schluterman, M.K., Barnes, R., King, I.N., et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270, 2005.
29. Yoshioka, M., Yuasa, S., Matsumura, K., Kimura, K., Shiomi, T., Kimura, N., et al. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med 12, 1151, 2006.
30. Nakajima, Y., Yamagishi, T., Hokari, S., and Nakamura, H. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat Rec 258, 119, 2000.
31. Dor, Y., Camenisch, T.D., Itin, A., Fishman, G.I., McDonald, J.A., Carmeliet, P., et al. A novel role for VEGF in endocar-dial cushion formation and its potential contribution to congenital heart defects. Development 128, 1531, 2001.
32. Combs, M.D., and Yutzey, K.E. VEGF and RANKL regulation of NFATc1 in heart valve development. Circ Res 105, 565, 2009.
33. Jackson, L.F., Qiu, T.H., Sunnarborg, S.W., Chang, A., Zhang, C., Patterson, C., et al. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 22, 2704, 2003.
34. Sucosky, P., Balachandran, K., Elhammali, A., Jo, H., and Yoganathan, A.P. Altered shear stress stimulates upregula-tion of endothelial VCAM-1 and ICAM-1 in a BMP-4-and TGF-beta1-dependent pathway. Arterioscler Thromb Vasc Biol 29, 254, 2009.
35. Schmidt, D., Mol, A., Breymann, C., Achermann, J., Oder-matt, B., Gossi, M., et al. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation 114, I125, 2006.
36. Perry, T.E., Kaushal, S., Sutherland, F.W., Guleserian, K.J., Bischoff, J., Sacks, M., et al. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Ann Thorac Surg 75, 761; discussion 7, 2003.
37. Sales, V.L., Mettler, B.A., Engelmayr, G.C., Aikawa, E., Bis-choff, J., Martin, D.P., et al. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng Part A 16, 257, 2010.
38. Jia, Q., McDill, B.W., Li, S.Z., Deng, C., Chang, C.P., and Chen, F. Smad signaling in the neural crest regulates cardiac outflow tract remodeling through cell autonomous and non-cell autonomous effects. Dev Biol 311, 172, 2007.